July 2015 | HCC Monitor

Immuno-Oncology Arrives in HCC

July 01, 2015

Clinical Articles

The ASCO Annual Meeting is always packed with the latest and greatest advances in the field of oncology, and this year was no exception! The 2015 meeting had posted record-breaking numbers for abstract submissions and attendance, with over 37,000 individuals crowding the halls of the McCormick Place in Chicago.

Novel Agents Show Early Promise in HCC

July 22, 2015

Clinical Articles

A collection of early phase clinical trials presented at the 2015 ASCO Annual Meeting demonstrated promising results for several novel agents in combination with established treatments for patients with hepatocellular carcinoma (HCC).

Hepatitis B Confers Worse Outcomes, More Advanced Disease

July 22, 2015

Clinical Articles

Patients with hepatocellular carcinoma (HCC) that was related to hepatitis B virus (HBV) infection were found to have more advanced clinicopathologic features and worse outcomes compared with those with hepatitis C virus (HCV)-related HCC.

Transplant Versus Resection for Hepatocellular Carcinoma

July 23, 2015

Clinical Articles

Although liver transplantation may be a more ideal treatment option compared with resection for many patients with hepatocellular carcinoma (HCC), donor availability remains a major limiting factor to its widespread incorporation.